Log in

NASDAQ:CLDXCelldex Therapeutics News Headlines

$1.73
+0.08 (+4.85 %)
(As of 04/6/2020 08:51 AM ET)
Add
Compare
Today's Range
$1.69
Now: $1.73
$1.85
50-Day Range
$1.55
MA: $2.17
$3.07
52-Week Range
$1.50
Now: $1.73
$5.47
Volume508,979 shs
Average Volume217,990 shs
Market Capitalization$30.41 million
P/E RatioN/A
Dividend YieldN/A
Beta2.88

Headlines

Celldex Therapeutics (NASDAQ CLDX) News Headlines

Source:
DateHeadline
Celldex Therapeutics IncCelldex Therapeutics Inc
www.bloomberg.com - March 29 at 12:46 AM
Celldex EPS beats by $0.29, beats on revenueCelldex EPS beats by $0.29, beats on revenue
seekingalpha.com - March 28 at 12:14 AM
Celldex Therapeutics (NASDAQ:CLDX) Releases  Earnings Results, Beats Expectations By $0.26 EPSCelldex Therapeutics (NASDAQ:CLDX) Releases Earnings Results, Beats Expectations By $0.26 EPS
www.americanbankingnews.com - March 27 at 9:07 AM
Celldex Therapeutics (NASDAQ:CLDX) Receives Buy Rating from HC WainwrightCelldex Therapeutics (NASDAQ:CLDX) Receives Buy Rating from HC Wainwright
www.americanbankingnews.com - March 27 at 7:59 AM
Celldex Provides Corporate Update and Reports Fourth Quarter and Year End 2019 ResultsCelldex Provides Corporate Update and Reports Fourth Quarter and Year End 2019 Results
finance.yahoo.com - March 26 at 6:43 PM
Celldex Therapeutics Announces $1.7 Million Milestone Payment from Rockefeller University Related to Collaboration on HIV Antibody ProgramCelldex Therapeutics Announces $1.7 Million Milestone Payment from Rockefeller University Related to Collaboration on HIV Antibody Program
finance.yahoo.com - March 3 at 8:17 AM
Cantor likes Celldex in premarket analyst actionCantor likes Celldex in premarket analyst action
seekingalpha.com - February 21 at 11:06 AM
Celldex Therapeutics, Inc. (CLDX) Pre-Market QuotesCelldex Therapeutics, Inc. (CLDX) Pre-Market Quotes
www.nasdaq.com - February 12 at 8:19 PM
Celldex Therapeutics, Inc. (CLDX) Insider ActivityCelldex Therapeutics, Inc. (CLDX) Insider Activity
www.nasdaq.com - February 12 at 8:19 PM
Celldex Therapeutics Inc.Celldex Therapeutics Inc.
www.barrons.com - February 6 at 11:40 PM
Celldex TherapeuticsCelldex Therapeutics
www.fool.com - February 6 at 11:40 PM
Is Celldex Therapeutics, Inc. (CLDX) A Good Stock To Buy?Is Celldex Therapeutics, Inc. (CLDX) A Good Stock To Buy?
finance.yahoo.com - December 23 at 2:42 PM
Celldex (CLDX) Down 3.9% Since Last Earnings Report: Can It Rebound?Celldex (CLDX) Down 3.9% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - December 12 at 1:18 PM
Celldex Initiates Phase 1 Study of KIT Inhibitor CDX-0159Celldex Initiates Phase 1 Study of KIT Inhibitor CDX-0159
finance.yahoo.com - November 18 at 12:31 PM
Celldex (CLDX) Q3 Loss Narrower Than Expected, Revenues MissCelldex (CLDX) Q3 Loss Narrower Than Expected, Revenues Miss
finance.yahoo.com - November 14 at 1:54 PM
Celldex Provides Corporate Update and Reports Third Quarter 2019 ResultsCelldex Provides Corporate Update and Reports Third Quarter 2019 Results
finance.yahoo.com - November 12 at 9:23 AM
Celldex Presents Promising Data from CDX-0159 and CDX-527 ProgramsCelldex Presents Promising Data from CDX-0159 and CDX-527 Programs
finance.yahoo.com - November 11 at 8:02 AM
CDX-1140 Demonstrates Clinical and Biological Activity in Patients with Advanced Solid Tumors in Phase 1 Dose Escalation StudyCDX-1140 Demonstrates Clinical and Biological Activity in Patients with Advanced Solid Tumors in Phase 1 Dose Escalation Study
finance.yahoo.com - November 8 at 10:50 AM
Will Celldex Therapeutics (CLDX) Report Negative Q3 Earnings? What You Should KnowWill Celldex Therapeutics (CLDX) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 30 at 1:32 PM
Celldex Therapeutics Announces Upcoming Data PresentationsCelldex Therapeutics Announces Upcoming Data Presentations
finance.yahoo.com - October 2 at 5:21 PM
Celldex Therapeutics to Present at the Cantor Global Healthcare ConferenceCelldex Therapeutics to Present at the Cantor Global Healthcare Conference
finance.yahoo.com - September 30 at 5:18 PM
Edited Transcript of CLDX earnings conference call or presentation 7-Aug-19 8:30pm GMTEdited Transcript of CLDX earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 14 at 9:53 AM
Kadmon (KDMN) Completes Enrollment in KD025 Study for cGVHDKadmon (KDMN) Completes Enrollment in KD025 Study for cGVHD
finance.yahoo.com - August 14 at 9:53 AM
Celldex (CLDX) Q2 Loss Narrower Than Expected, Revenues MissCelldex (CLDX) Q2 Loss Narrower Than Expected, Revenues Miss
finance.yahoo.com - August 9 at 1:20 AM
Celldex Therapeutics Inc (CLDX) Q2 2019 Earnings Call TranscriptCelldex Therapeutics Inc (CLDX) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 1:20 AM
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q2 2019 Results - Earnings Call TranscriptCelldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 11:12 AM
Celldex Therapeutics Keeps Up Its Penny-Pinching and Pipeline ProgressCelldex Therapeutics Keeps Up Its Penny-Pinching and Pipeline Progress
finance.yahoo.com - August 8 at 11:12 AM
Celldex Provides Corporate Update and Reports Second Quarter 2019 ResultsCelldex Provides Corporate Update and Reports Second Quarter 2019 Results
www.marketwatch.com - August 7 at 9:59 PM
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue EstimatesCelldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 7 at 9:59 PM
Celldex to Report Second Quarter 2019 Financial Results and Host Corporate Update CallCelldex to Report Second Quarter 2019 Financial Results and Host Corporate Update Call
finance.yahoo.com - July 31 at 10:47 PM
Celldex Therapeutics Appoints Diane C. Young, M.D. as Senior Vice President, Chief Medical OfficerCelldex Therapeutics Appoints Diane C. Young, M.D. as Senior Vice President, Chief Medical Officer
feeds.benzinga.com - June 24 at 8:40 AM
Why Is Celldex (CLDX) Down 29.2% Since Last Earnings Report?Why Is Celldex (CLDX) Down 29.2% Since Last Earnings Report?
finance.yahoo.com - June 6 at 6:40 PM
Celldex Announces Data from CDX-3379 Clinical Program Presented at ASCO 2019; Promising Biomarker Strategy Identified for Head and Neck Squamous Cell CarcinomaCelldex Announces Data from CDX-3379 Clinical Program Presented at ASCO 2019; Promising Biomarker Strategy Identified for Head and Neck Squamous Cell Carcinoma
finance.yahoo.com - June 1 at 5:21 PM
Celldex Therapeutics (CLDX) Reports Q1 Loss, Tops Revenue EstimatesCelldex Therapeutics (CLDX) Reports Q1 Loss, Tops Revenue Estimates
www.nasdaq.com - May 8 at 8:47 AM
Celldex Therapeutics Continues to Stretch Out Its Cash and Advance Its PipelineCelldex Therapeutics Continues to Stretch Out Its Cash and Advance Its Pipeline
www.fool.com - May 8 at 7:34 AM
Celldex Provides Corporate Update and Reports First Quarter 2019 ResultsCelldex Provides Corporate Update and Reports First Quarter 2019 Results
www.marketwatch.com - May 7 at 6:41 PM
Celldex Therapeutics (CLDX) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseCelldex Therapeutics (CLDX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - May 2 at 7:41 PM
Celldex (CLDX) Down 5.7% Since Last Earnings Report: Can It Rebound?Celldex (CLDX) Down 5.7% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - April 6 at 5:47 PM
Celldex Presents Positive Interim Results from Phase 1 Study of CD40 Agonist CDX-1140 at American Association for Cancer Research (AACR) Annual Meeting 2019Celldex Presents Positive Interim Results from Phase 1 Study of CD40 Agonist CDX-1140 at American Association for Cancer Research (AACR) Annual Meeting 2019
finance.yahoo.com - April 2 at 9:32 AM
Celldex Presents Promising Data from CDX-527 Bispecific and TAM Receptor Programs at American Association for Cancer Research (AACR) Annual Meeting 2019Celldex Presents Promising Data from CDX-527 Bispecific and TAM Receptor Programs at American Association for Cancer Research (AACR) Annual Meeting 2019
finance.yahoo.com - April 1 at 7:34 PM
Is Celldex Therapeutics (CLDX) Stock Outpacing Its Medical Peers This Year?Is Celldex Therapeutics (CLDX) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - March 20 at 9:15 PM
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2018 Results - Earnings Call TranscriptCelldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 8 at 8:54 AM
Celldex Therapeutics Cost-Cutting and Reverse Stock Split Help Keep It RollingCelldex Therapeutics' Cost-Cutting and Reverse Stock Split Help Keep It Rolling
www.fool.com - March 8 at 8:54 AM
Edited Transcript of CLDX earnings conference call or presentation 7-Mar-19 9:30pm GMTEdited Transcript of CLDX earnings conference call or presentation 7-Mar-19 9:30pm GMT
finance.yahoo.com - March 8 at 8:54 AM
Celldex Therapeutics, Inc (CLDX) Q4 2018 Earnings Conference Call TranscriptCelldex Therapeutics, Inc (CLDX) Q4 2018 Earnings Conference Call Transcript
www.fool.com - March 7 at 10:07 PM
Celldex Provides Corporate Update and Reports Full Year 2018 ResultsCelldex Provides Corporate Update and Reports Full Year 2018 Results
finance.yahoo.com - March 7 at 6:40 PM
Celldex Therapeutics (CLDX) Stock Sinks As Market Gains: What You Should KnowCelldex Therapeutics (CLDX) Stock Sinks As Market Gains: What You Should Know
finance.yahoo.com - February 22 at 6:45 PM
Analysis: Positioning to Benefit within Applied Materials, MRC Global, Meritor, Celldex Therapeutics, Quaker Chemical, and Cubic — Research Highlights Growth, Revenue, and Consolidated ResultsAnalysis: Positioning to Benefit within Applied Materials, MRC Global, Meritor, Celldex Therapeutics, Quaker Chemical, and Cubic — Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - February 20 at 8:56 AM
The Celldex Reverse Stock Split: What Investors Need To KnowThe Celldex Reverse Stock Split: What Investors Need To Know
finance.yahoo.com - February 11 at 6:19 PM
Post-reverse split trading in Celldex commences today; shares down 12% premarketPost-reverse split trading in Celldex commences today; shares down 12% premarket
seekingalpha.com - February 11 at 9:51 AM
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel